Patents by Inventor Peter Lach

Peter Lach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Patent number: 10105323
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: October 23, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Roman Messerschmid, Peter Lach, Torsten Sokoliess, Peter Stopfer, Dirk Trommeshauser
  • PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONE DERIVATIVE
    Publication number: 20170239191
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 24, 2017
    Inventors: Roman MESSERSCHMID, Peter LACH, Torsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20170065529
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 9, 2017
    Inventors: Roman MESSERSCHMID, Peter LACH, Thorsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • Instrument stand with seat
    Patent number: 8845017
    Abstract: A combination instrument stand and seat has a support structure having at least one leg, and a seat pivotally mounted on the support structure with a seat pivot element to pivot between a horizontal position and a tilted position. A latch mechanism is adapted for locking the seat in the horizontal position. An instrument support extends from the support structure and is shaped to cradle a bottom of the instrument.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: September 30, 2014
    Inventor: Paul Peter Lach
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20140163040
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: February 10, 2014
    Publication date: June 12, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Roman MESSERSCHMID, Peter LACH, Thorsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20130203773
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: March 8, 2013
    Publication date: August 8, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Roman MESSERSCHMID, Peter LACH, Thorsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20110190318
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: June 4, 2009
    Publication date: August 4, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Roman Messerschmid, Peter Lach, Torsten Sokoliess, Peter Stopfer, Dirk Trommeshauser